Exact FDA event identifier

Event 90384

1 recalled-product record grouped only because every row carries this exact official event ID.

Event summary

Timeline bucket: June 09, 2022
Product types: Drug
Classifications: Class I
Statuses: Terminated
Recalling firm wording: Green Pharmaceuticals, Inc.

Dossier provenance

Source snapshots represented here

openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Device root-cause evidence is not applicable to this event. No grouped product has the official product type device; this is not an unavailable-enrichment finding.

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

SnoreStop NasoSpray, 0.3 FL OZ (9 mL), Green Pharmaceuticals Inc. Camarillo, CA 93012, NDC 61152-199-99, UPC 7 69682 29101 3

D-1165-2022

Recall number: D-1165-2022
Initiated: June 09, 2022
Classification: Class I
Status: Terminated
Recalling firm: Green Pharmaceuticals, Inc.
Quantity: 1074 spray bottles

App-derived interpretation

Microbial contamination reason.microbial_contamination · v1.0.0

Microbial contamination

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Microbial contamination of non-sterile product: FDA laboratory analysis found product to contain microbial contamination identified as Providencia rettgeri.

Code information

Lot #: 2373/21222

Distribution pattern

Nationwide within the United States